Over-expression of Anillin Actin Binding Protein in Adrenocortical Carcinoma Tissues Is Associated With Poorer Prognosis of Patients
<i>ANLN</i> may be a prognostic biomarker for patients with ACC and may play a role in tumor biology. Further studies are needed to determine whether <i>ANLN</i> is clinically useful as a prognostic factor in the treatment of ACC and to clarify its involvement in the mechanism of malignant progression of ACC.
Authors
- YASUHIRO KURAMITSU
- Durga Paudel (ORCID: https://orcid.org/0000-0002-5166-3221)
- SHIN-NOSUKE YAMASHITA
- Fumiya Harada (ORCID: https://orcid.org/0000-0002-8312-5903)
- Hiroki Nagayasu
- Kazuhiro Tokuda (ORCID: https://orcid.org/0000-0003-3606-3102)
- Takao Kitagawa (ORCID: https://orcid.org/0000-0001-7753-827X)
- Sarita Giri (ORCID: https://orcid.org/0000-0001-6157-3003)
- Tohru Ohta
- Shajedul Islam
- Yoshiatsu Tanaka
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Health Sciences University of Hokkaido (JP)
- Yamaguchi Prefectural University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2026-01-30
- DOI
- https://doi.org/10.21873/anticanres.17994
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.00